Penn Immunology PhD student @Carlhjune Lab • Flagship Pioneering Fellow 24 • PCI Fellow 24-25 • NSF GRFP • Prev @YaleUniversity Biomedical Engineering @RongFan8
Joined March 2019
- Tweets383
- Following396
- Followers427
- Likes2.5K
Pinned Tweet
It was great to speak with @bradloncar @BiotechTVHQ about my thesis work in @carlhjune’s lab and about the initiative @KristenHege started to support early career women here at the Center for Cellular Immunotherapies
This Post is from an account that no longer exists. Learn more
AmandaFinck retweeted
Very excited to see the progress in RVCL from the amazing @miner_lab. We are very appreciative of the support from the Clayco Foundation for this transformational acceleration in RVCL work and for the #ColtonConsortium for initially support some of this work.
A $10M gift from the Clayco Foundation will accelerate the development of a new therapy for RVCL, a rare, fatal disease with no cure ft. @miner_lab (@PennRheum) & @FinckAmanda (@RVCL_research) @UPenn_I3H tinyurl.com/yeyve4fy
AmandaFinck retweeted
A $10M gift from the Clayco Foundation will accelerate the development of a new therapy for RVCL, a rare, fatal disease with no cure ft. @miner_lab (@PennRheum) & @FinckAmanda (@RVCL_research) @UPenn_I3H tinyurl.com/yeyve4fy
AmandaFinck retweeted
Congratulations to Sam Chauvin for his successful doctoral thesis defense!
Sam worked tirelessly to define disease mechanisms and advance precision therapies for RVCL.
Sam is a 6th year MD/PhD student at Penn. Now he is returning to the final years of medical school training, with the goal of becoming a pediatric oncologist and a laboratory-based physician-scientist.
AmandaFinck retweeted
Spectacular discovery that STING GOF mutations can strike adults:
Adult-onset STING-associated vasculopathy rupress.org/jhi/article/2/4/…
AmandaFinck retweeted
STING gain-of-function has primarily been described to cause pediatric-onset disease. Here, Riley, Kotzin, @FinckAmanda, @miner_lab et al. report a surprisingly high prevalence of adult-onset #SAVI among patients with common #autoimmune disease diagnoses. hubs.la/Q04g4NGQ0
🚨Paper alert from the June Lab🚨
What if the better answer to solid tumor CAR T cells lies outside the tumor itself?
(1/10)
👩🔬👨🔬All good science is team science! Grateful to all of my co-authors: Ziming Wang, Donna Gonzales, Nils Wellhausen, @msofiacastelli, Esha Banerjee, @MAngelaAznar, and to my mentors @carlhjune and Regina Young. Special thanks to past & present lab members as well!
(9/10)
Read more in our PNAS paper here ---> lnkd.in/eSekahmv
(10/10)
AmandaFinck retweeted
“Are you improving the world? Is the world better than it was?” — Dr. Bruce Levine.
An inspiring documentary on @BLLPHD groundbreaking work in CAR T cell therapy, a powerful story of science, dedication, and vision, beautifully narrated by @FinckAmanda!
youtube.com/watch?v=YrevpY-D…
AmandaFinck retweeted
Excited to share my PhD thesis work with @CarlHJune now out as a preprint on bioRxiv! We show that engineering IL-9 signaling enhances CAR T cell antitumor efficacy by steering them toward potent memory and effector states.
biorxiv.org/content/10.1101/…
AmandaFinck retweeted
Grateful to be named a 2024 RISE Scholar by @parkerici, alongside this incredible group of researchers driving advancements in cancer immunotherapy. Honored to be part of this effort toward a future where all cancers are curable!
We are thrilled to share the 2024 class of Representation in SciencE (RISE) Scholars, a group of seven exceptional researchers selected through our Diversity, Equity, Inclusion and Belonging (DEIB) Program. Read our latest blog: parkerici.org/the-latest/par…
AmandaFinck retweeted
Faculty position open @YaleAge !!!
At @YaleAge, we are seeking applications for up to 2 tenure-track positions at Asst. or Associate Professor level to build an interdisciplinary research program in basic biology of #aging. We seek outstanding scientists interested in aging & #geroscience. apply.interfolio.com/156291
AmandaFinck retweeted
Excited to share our new story from the lab in close collaboration with the Love lab @kochinstitute. Here is brief summary: ever wondered where T cells expand following immune checkpoint blockade therapy? The answer is in the white pulp of the spleen.